Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and P... (tory markers reducing fatigue (poor ener...)

HOME >> MEDICINE >> TECHNOLOGY

Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance

Date:1/29/2008

tory markers, reducing fatigue (poor energy recovery) and the breakdown of muscle (post exercise wasting), as well as the lessening of free radical production (oxidative stress). The formula meets NCAA guidelines for use by collegiate athletes and is certified by The Banned Substances Control Group (BSCG) to contain no banned substances.

About Millennium:

Millennium's three proprietary, marketed products, which form the Company's Resurgex(R) Continuum of Care, include Resurgex Select(R), Resurgex(R), and Resurgex Plus(R). Resurgex Select(R) is a whole foods-based, calorically dense, high-protein nutritional formula developed for cancer patients undergoing chemotherapy or radiation treatments. Resurgex(R) and Resurgex Plus(R) are specialized, anabolic nutritional supplements rich in antioxidants that provide nutritional support post-treatment. Millennium is also recently developed a Surgex(TM) sports nutrition formula, clinically proven to address the nutritional concerns of the Professional, Olympic and amateur elite athletes. These athletes often experience similar symptoms post- workout to those battling immuno-compromised conditions, such as fatigue, loss of lean muscle, oxidative stress, and reduced immune function.

Statements in this news release regarding future financial and operating results, future growth in R&D programs, potential applications of the Company's technology, opportunities for the Company, and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results o
'/>"/>

SOURCE Millennium Biotechnologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Takeda Doses First Patient in a U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Induced Anemia
2. Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
3. Cleveland Clinic to Lead First Head-to-Head Comparison of the Two Most Potent Statins
4. First Patient Enrolled in Cogentus Pharmaceuticals Pivotal Phase 3 Trial of Novel Combination Medicine
5. VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation
6. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
7. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
8. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
9. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
10. Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting
11. YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter

Post Your Comments:

(Date:12/15/2009)... 15 Estill Medical Technologies, Inc., a family-owned ... and IV Fluid Infusion Warmer , a patented medical ... military and emergency responders to lessen ... CALSTAR 6 Unit of South Lake Tahoe as the ... Year Award." ,, CALSTAR is a California-based ...

(Date:12/15/2009)... Decision Resources, one of the world,s leading research ... finds that an overall survival benefit would be ... European oncologists in their decision to prescribe a ... of breast cancer. ,, The new Special European ... Trends in Targeted Therapies in Breast Cancer: A ...

(Date:12/15/2009)... Mass., Dec. 15 OBP Medical Inc. ... and overall patient satisfaction in hospitals. ,, Doctors ... the positive effects of OBP Medical,s Under Johnnies(TM) ... stay. A hospital wide survey is comparing patients, ... their stay while wearing Under Johnnies(TM) against the ...

Breaking Medicine Technology:Thermal Angel Blood Warmer Recognizes CALSTAR 6 With Distinguished Emergency Responder Award 2 Thermal Angel Blood Warmer Recognizes CALSTAR 6 With Distinguished Emergency Responder Award 3 Thermal Angel Blood Warmer Recognizes CALSTAR 6 With Distinguished Emergency Responder Award 4 For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 2 For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 3 Under Johnnies(TM) Proven To Increase Patient Satisfaction by OBP Medical Inc. 2 Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 1 Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 2 Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 3 Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 4 Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 5 ULURU Inc Announces Status of York Note Receivable 52851 1 ULURU Inc Announces Status of York Note Receivable 52851 2 VIDEO from Medialink and the American Academy of Orthopaedic Surgeons 3A American Joint Replacement Registry Announced 52848 1 VIDEO from Medialink and the American Academy of Orthopaedic Surgeons 3A American Joint Replacement Registry Announced 52848 2

[0] Thermal Angel Blood Warmer Recognizes CALSTAR 6 With Distinguished Emergency Responder Award [0] For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe [0] Under Johnnies(TM) Proven To Increase Patient Satisfaction by OBP Medical Inc.

... Trial Shows CRESTOR Slowed Progression Of Atherosclerosis,In People ... March 26, 2006-AstraZeneca today announced that the,METEOR clinical ... show a,positive effect on atherosclerosis in people with ... risk of coronary heart disease,(CHD). ,The study, ...

... Bioabsorbable Stent Technology Holds Promise as,Future-Generation Treatment ... Disease, ABBOTT PARK, Ill., March 24, 2007 ... ABSORB, the world's,first clinical trial evaluating the ... drug- eluting stent platform for the,treatment of ...

Other Medicine Technology:First Study To Show Positive Benefit On Atherosclerosis For People,With Early Signs Of Diseased Arteries 2 First Study To Show Positive Benefit On Atherosclerosis For People,With Early Signs Of Diseased Arteries 3 First Study To Show Positive Benefit On Atherosclerosis For People,With Early Signs Of Diseased Arteries 4 First Study To Show Positive Benefit On Atherosclerosis For People,With Early Signs Of Diseased Arteries 5 Abbott Announces Positive Six-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent 2 Abbott Announces Positive Six-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent 3

First Study To Show Positive Benefit On Atherosclerosis For People,With Early Signs Of Diseased Arteries Abbott Announces Positive Six-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent

(Date:12/15/2009)... a direct correlation between effective workplace health programs ... of health improvement can result in lower costs ... paper from The Vitality Group, a provider of ... setting for the delivery of health and wellness ... of health is a critical component in implementing ...

(Date:12/15/2009)... 15 Today, Coastal Healthcare Administrators ... County for the first time since its ... Healthcare Administrators will be assuming responsibilities and ... Foundation for Medical Care. ,, Operating ... maintains close working relationships with all network ...

(Date:12/15/2009)... cancer cells may offer a new option to treat ... by amplified signaling of the epidermal growth factor receptor ... UCLA,s Jonsson Comprehensive Cancer Center. , Rapidly dividing cancer ... membranes. The fatty acids also provide an alternative energy ... for regulating cell signaling, said Dr. Paul Mischel, a ...

(Date:12/15/2009)... generally associated with different tests and/or prescriptions for ... doctors and midwives are agreed that gynaecological visits ... reveals a thesis from the Sahlgrenska Academy at ... women see sex as a problem, the thesis ... about their sex lives, their relationships and how ...

(Date:12/15/2009)... A new study published by The University of Western ... paid and unpaid work report higher average measures of ... models. , The ,shared roles, category, where each partner,s ... total unpaid work, is a growing category that now ... are more likely to be in a shared roles ...

Breaking Medicine News(10 mins):Health News:Optimizing Corporate Culture is Critical to the Success of Wellness Programs 2 Health News:Coastal Healthcare Administrators Expands Provider Network to Santa Clara County 2 Health News:Targeting brain cancer cell metabolism may provide new treatment 2 Health News:Targeting brain cancer cell metabolism may provide new treatment 3 Health News:More about sex and relationships needed at gynecological visits 2

[0] Optimizing Corporate Culture is Critical to the Success of Wellness Programs [0] Coastal Healthcare Administrators Expands Provider Network to Santa Clara County [0] Targeting brain cancer cell metabolism may provide new treatment [0] More about sex and relationships needed at gynecological visits [0] Couples who do the dishes together stay happier

... is a statement by Matthew L. Myers, President, ... Energy and Commerce Committee today set Congress on ... reduce tobacco use by approving legislation granting the ... products. Today,s 39-13 vote underscores the broad, ...

... 4 National Center for Creative Aging (NCCA) will present ... as a way to engage people with dementia. The ... will be held in Washington, D.C. on March 30, ... "Cases of dementia and Alzheimer,s disease increase with age, so ...

... TSMFG.com is the Single Source Solution for Safety Supplies, Face ... Now, thanks to industry pioneer Total Source ... their contamination control needs. In the past it was necessary ... narrow range of safety supply products, ...

... of heart disease over and above any genetic risks common ... University School of Medicine in St. Louis and the VA. ... of the American Psychosomatic Society this week in Chicago. , ... twins who served in the U.S. military during the Vietnam ...

... lung cancer," but only 50 can say they,ve completed ... chances of surviving the deadly disease and without ... Radiation Oncology Department say the technique, stereotactic body radiotherapy, ... surviving early stage lung cancer, but may reduce the ...

... Watchers International, Inc. (NYSE: WTW ) today announced ... which ended January 3, 2009. Fourth Quarter 2008 Results ... $2.2 million to $346.2 million, up from $344.0 million in ... of $7.8 million to revenue, net revenues were down $5.6 ...

House Committee Vote Sets Congress on Course for Historic Regulation of Tobacco Products National Center for Creative Aging Presents 'Creativity Matters' Symposium on Health, Wellness, and the Arts Total Source Manufacturing (TSMFG.com) - A Contamination Control Pioneer Depression increases risk for heart disease more than genetics or environment Surviving lung cancer Weight Watchers Announces Fourth Quarter and Full Year 2008 Results

... Perfusion Catheter is indicated for ... portion of a coronary artery ... the purpose of improving myocardial ... are also designed to provide ...

The GE e-Speed™scanner, the worlds fastest computed tomography (CT) imaging platform, delivers a new advanced tool for physicians to see and diagnose heart disease....

...

Angled 45 Degrees to Right, 9.5mm blade, gently curved .5x .25mm blunt tips; Lower blade is 0.5mm longer; 14mm from mid screw to tip; (Available in left and right;) overall length 120mm; Stainless ...

Medicine Products:

Surpass Superfusion Long EBT e-Speed™Vannas Straight Capsulotomy Scissors Corneal Section Scissors (Castroviejo) LEFT

Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and P...(tory markers reducing fatigue (poor ener...),Health